CD Antigen Cancer Therapy Market Size, Share, Analysis and Forecast 2023 – 2033
The Global CD Antigen Cancer Therapy Market Size is Anticipated to Exceed USD 13.3 Billion by 2033, Growing at a CAGR of 11.95% from 2023 to 2033. CD antigen cancer therapy occurs by targeting specific CD markers on cancer cells, allowing for greater accuracy treatment. Therapies such as CAR T-cells and monoclonal antibodies target tumours selectively by recognizing these cell membrane proteins, improving therapy efficacy while preventing harm to healthy cells.